MIAMI, June 27, 2018 (GLOBE NEWSWIRE) -- Progressive Care, Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that it has engaged The Benchmark Company, LLC as a financial advisor as it moves forward with the process of re-registration with the U.S. Securities and Exchange Commission and pursues a listing on a national securities exchange.

“At Progressive Care we have been actively pursuing an aggressive growth strategy, which includes the stated goal of fully reporting to the SEC and uplisting to a national exchange like NASDAQ,” said S. Parikh Mars, CEO of Progressive Care Inc. “We believe The Benchmark Company will provide us with the guidance, expertise, and access to capital we need to be further successful on all fronts of our development.”

For more information about Progressive Care, please visit the company’s website.

About Progressive Care, Inc.
Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

About The Benchmark Company, LLC
The Benchmark Company, LLC founded in 1988, is a full-service investment banking and financial advisory firm with a sales & trading platform servicing institutional clients in all major markets in the US and internationally. They employ a team of research analysts covering companies in the Technology, Media, Publishing, Broadcasting, Business Services, Consumer/Retail, and Healthcare sectors. Benchmark also employs an investment banking team providing corporate finance and advisory services to small and mid-sized companies. Benchmark is headquartered in New York with offices in 10 other financial centers in the U.S.